Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39929 |
MS21
|
PROTACs | PROTAC |
MS21 is a unique AKT degrader that selectively hampers the proliferation of cancers with mutations in the PI3K/PTEN pathway, alongside wild-type KRAS and BRAF. | |||
T5828 |
MS21570
5-(苄基硫代)-N-甲基-1,3,4-噻二唑-2-胺 |
GPR | Endocrinology/Hormones; GPCR/G Protein |
MS21570 作为 GPR171 拮抗剂基于其阻断能力,IC50 为 220 nM,可减少小鼠的焦虑样行为和恐惧条件反射。 | |||
T67746 |
IMS2186
|
Others | Others |
IMS2186 是一种抗脉络膜新生血管 (CNV) 试剂, 可以使癌细胞周期阻滞在 G2/M 期,由此产生抗增殖和抗血管生成作用。IMS2186 能够减少眼睛渗漏和病变细胞的数量,并且无眼内毒性。 | |||
T24501 |
MS2126
NSC 71584,NSC71584,MS 2126,MS-2126,NSC-71584 |
||
MS2126 is a Human p53 and CREB Binding Protein interaction inhibitor. | |||
T28114 |
MS2177
MS 2177,MS-2177 |
||
MS2177 is a potent and selective inhibitor of SETD8, the only methyltransferase known to catalyze monomethylation of histone H4 lysine 20 (H4K20). MS2177 has an in vitro IC50 of 1.9 μM (σ = 1.05 μM, n = 4) in ascintillation proximity assay. Binding of MS2 |